Tongue Cancer
📧 Sign up to get email alerts when something new happens for Tongue Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2014-06-06Clinical Trial Update: Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer [Phase 1]
This Phase 1 clinical trial update examines a combination regimen of Erlotinib, Docetaxel, and radiation therapy for locally advanced head a…
-
CLINICAL_TRIALS trial_result · 2013-05-17Clinical Trial Update: Effects of Different General Anesthesia Methods on Immune Responses in Patients Undergoing Surgery for Tongue Cancer [NA]
A clinical trial update describes a study comparing different general anesthesia methods and their effects on immune responses in patients u…
-
CLINICAL_TRIALS trial_result · 2013-05-16Clinical Trial Update: GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer [Phase 3]
Phase 3 trial evaluating GM-CSF mouthwash to prevent and treat mucositis in patients undergoing radiation therapy for head and neck cancer; …
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: S0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [Phase 2]
This document provides an update on a Phase 2 trial of sorafenib for patients with recurrent or metastatic head and neck cancer and indicate…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Gene Therapy in Preventing Cancer in Patients With Premalignant Carcinoma of the Oral Cavity or Pharynx [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating a gene therapy approach to prevent progression to cancer in premalignant lesions of the lip and oral cav…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2013-01-04Clinical Trial Update: CETUXIMAB Given for 3 Weeks as Neoadjuvant Treatment in Locally Advanced Tongue Cancer ; A NEW PARADIGM OF TREATMENT [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluates cetuximab given for three weeks as neoadjuvant therapy for locally advanced tongue cancer/oral squamous…
-
CLINICAL_TRIALS trial_result · 2012-12-27Clinical Trial Update: Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck [Phase 2]
Phase 2 trial evaluating bortezomib with or without irinotecan in locally recurrent or metastatic squamous cell carcinoma of the head and ne…